Article
AbbVie's blood cancer combo therapy fails in late-stage study
Rating:
0.0
Views:
68
Likes:
1
Library:
1
AbbVie said on Friday a late-stage study of its experimental combination therapy to treat a form of blood cancer failed to meaningfully increase the survival rate of patients without the disease worsening.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value